Sarcoma uterino

+ -Text Size

Otros recursos y referencias TEMAS

Referencias: Guía detallada del sarcoma uterino

Amant F, Coosemans A, Renard V, Everaert E, Vergote I. Clinical outcome of ET-743 (Trabectedin; Yondelis) in high-grade uterine sarcomas: report on five patients and a review of the literature. Int J Gynecol Cancer. 2009;19:245-248.

American Cancer Society. Cancer Facts and Figures 2014. Atlanta, Ga: American Cancer Society; 2014.

American Joint Committee on Cancer. Corpus Uteri. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010: 403-409.

Bodurka DC, Gershenson DM. Sarcomas of the female reproductive tract. In: Pollock RE, ed. American Cancer Society Atlas of Clinical Oncology. Soft Tissue Sarcomas. Hamilton, Ontario: BC Decker; 2002:213-227.

Chan JK, Kawar NM, Shin JY, et al. Sarcoma estromal endometrial: a population-based analysis. Br J Cancer. 2008;99:1210-1215.

Fields A, Jones JG, Thomas GM, Runowicz CD. Gynecologic cancer. In: Lenhard RE Jr, Osteen RT, Gansler T, eds. Clinical Oncology. Atlanta, Ga: American Cancer Society; 2001:455-496.

Francis JH, Kleinerman RA, Seddon JM, Abramson DH. Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol. 2012 Feb;124(2):254-9. Epub 2011 Oct 23.

Hensley ML, Ishill N, Soslow R, et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. Gynecol Oncol. 2009;112:563-567.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.

Hrzenjak A, Moinfar F, Tavassoli FA, et al. JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue. J Mol Diagn. 2005;7:388-395.

Kosary CL. Cancer of the Corpus Uteri. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (editors). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

Lee CH, Mariño-Enriquez A, Ou W, et al. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol. 2012 May;36(5):641-53.

National Comprehensive Cancer Network Uterine Neoplasms. V.3.2012. Accessed at www.nccn.org on April 24, 2012.

Nucci MR, Harburger D, Koontz J, Dal Cin P, Sklar J. Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol. 2007 Jan;31(1):65-70.

PDQ database. Uterine sarcoma. Bethesda, Md: National Cancer Institute; 10/18/2012. Accessed at http://www.cancer.gov/cancertopics/pdq/treatment/uterinesarcoma/healthprofessional on December 7, 2012.

Rahaman J, Cohen CJ. Gynecologic sarcomas. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E, eds. Cancer Medicine 6. Hamilton, Ontario: BC Decker; 2003:1871-1878.

Ramirez PT, Mundt AJ, Muggia FM. Cancers of the uterine body. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cáncer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins 2011: 1345-1362.

Reed NS, Mangioni C, Malmström H, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer. 2008 Apr;44(6):808-18. Epub 2008 Apr 2. Erratum in: Eur J Cancer. 2008 Jul;44(11):1612.


Fecha de última actualización: 02/14/2013
Fecha de último cambio o revisión: 02/12/2014